May 2022

BTC’s biggest study is opening this summer

Patients with pneumonia are at a higher risk of having a stroke or cardiac event for 3-months post infection. ASPECT aims to answer the question of whether low dose aspirin will help reduce this risk by collecting data from patients at more than 60 hospital sites across England.

22,600 patients will be randomised to either receive aspirin or not. Due to its size, ASPECT is being set up to be very light touch for the patients and the research teams delivering the study. To do this we will be requesting study data from NHS Digital and therefore will not have to conduct patient follow-ups.

If your site is interested in participating in ASPECT, or you would like more information, please contact: aspect-trial@bristol.ac.uk

Study Coordinator: Sam Thomson-Hill

Twitter: @AspectStudy


This study is funded by the NIHR Health Technology Assessment Programme (Ref: NIHR132968). The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health and Social Care.